That is not a secondary benefit
Studies in a Since semaglutide mimics the function of GLP-1, the drug may alter your perception of sweet foods and reduce your desire to eat them
Moreover, it appears that it is the membrane-bound form of the enzyme, on sites such as the luminal surface of capillary endothelial cells, which is more important for GLP-1 degradation than the circulating (soluble) enzyme (74, 75), questioning the relevance of any association between the plasma activity per se and glycaemic control, since it is unclear whether changes in soluble DPP-4 activity in the circulation accurately reflect any changes in total DPP-4 activity
The content is not intended to be a substitute for professional medical diagnosis or treatment
A recent JAMA study ran the numbers, and the findings werent pretty: Tirzepatides ICER was $197,023/QALY Semaglutides ICER was $467,676/QALY So what does that mean